Lantheus Holdings Inc (LNTH)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $6.64B
Last updated: Nov 17, 2026 at 11:06 AM ET
Lantheus Holdings Inc (LNTH) Financials: Revenue, Profit and Cash Flow
Lantheus Holdings reported revenue of $1.54B for the fiscal year ended Dec 31, 2025, up 0.5% from the year before. That year, net income was $233.56M with a net margin of 15.2%, operating cash flow was $390.14M and free cash flow was $354.05M. The quarter ended Sep 30, 2026 had revenue of $389.91M and net income of $22.37M.
Revenue and Margins
The operating margin was 20.2% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $301.85M, a compound annual rate of 19.8%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $1.54B | +0.5% | 61.1% | 20.2% | 15.2% |
| Dec 2024 | $1.53B | +18.3% | 64.4% | 29.8% | 20.4% |
| Dec 2023 | $1.30B | +38.6% | 54.7% | 28.1% | 25.2% |
| Dec 2022 | $935.06M | +119.9% | 62.2% | 3.9% | 3.0% |
| Dec 2021 | $425.21M | +25.3% | 44.1% | -14.3% | -16.8% |
| Dec 2020 | $339.41M | -2.3% | 40.9% | -1.2% | -4.0% |
| Dec 2019 | $347.34M | +1.2% | 50.3% | 14.9% | 9.1% |
| Dec 2018 | $343.37M | +3.6% | 50.9% | 18.8% | 11.8% |
| Dec 2017 | $331.38M | +9.8% | 48.9% | 15.6% | 37.2% |
| Dec 2016 | $301.85M | N/A | 45.6% | 18.7% | 8.9% |
Income Statement
In the fiscal year ended Dec 2025, net income fell 25.2% from the year before. In the quarter ended Sep 2026, net income fell 19.4% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.54B | $1.53B | $1.30B | $935.06M | $425.21M | $339.41M | $347.34M | $343.37M | $331.38M | $301.85M |
| Cost of revenue | $599.66M | $545.62M | $586.89M | $353.36M | $237.51M | $200.65M | $172.53M | $168.49M | $169.24M | $164.07M |
| Gross profit | $941.95M | $988.29M | $709.54M | $581.70M | $187.69M | $138.76M | $174.81M | $174.88M | $162.13M | $137.78M |
| Research and development | $177.31M | $168.10M | $77.71M | $311.68M | $44.97M | $32.79M | $20.02M | $17.07M | $18.13M | $12.20M |
| Operating income | $310.83M | $456.98M | $364.64M | $36.20M | -$60.83M | -$4.20M | $51.66M | $64.49M | $51.85M | $56.59M |
| Net income | $233.56M | $312.44M | $326.66M | $28.07M | -$71.28M | -$13.47M | $31.67M | $40.52M | $123.39M | $26.76M |
| EBITDA | $403.64M | $515.27M | $491.00M | $81.83M | -$25.00M | $22.69M | $55.62M | $80.88M | $77.28M | $73.17M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $389.91M | $388.18M | $377.33M | $406.79M | $384.01M | $378.05M | $372.76M | $391.11M | $378.73M | $394.09M | $369.98M | $354.00M |
| Gross profit | $243.41M | $241.85M | $230.92M | $240.88M | $222.37M | $241.01M | $237.70M | $248.54M | $242.13M | $255.77M | $251.78M | $229.87M |
| Operating income | $32.21M | $100.22M | $81.33M | $77.18M | $43.62M | $87.97M | $102.07M | $113.87M | $133.74M | $102.73M | $100.38M | $137.49M |
| Net income | $22.37M | $75.03M | $118.42M | $54.09M | $27.77M | $78.75M | $72.94M | -$11.79M | $131.09M | $62.07M | $131.07M | $103.38M |
Balance Sheet
As of Dec 2025, total debt of $569.42M exceeded cash and equivalents by $210.29M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $2.23B | $1.98B | $1.65B | $1.32B | $863.78M | $869.82M | $405.92M | $439.83M | $383.86M | $255.90M |
| Current assets | $899.96M | $1.33B | $1.09B | $677.62M | $235.79M | $184.22M | $172.91M | $195.41M | $147.85M | $110.82M |
| Cash and equivalents | $359.12M | $912.81M | $713.66M | $415.65M | $98.51M | $79.61M | $92.92M | $113.40M | $76.29M | $51.18M |
| Total liabilities | $1.14B | $892.33M | $835.26M | $874.11M | $399.35M | $355.62M | $291.32M | $368.83M | $360.57M | $362.41M |
| Short-term debt | $738.00K | $974.00K | $823.00K | $354.00K | $11.64M | $20.70M | $10.29M | $2.75M | $2.75M | $3.65M |
| Long-term debt | $568.68M | $565.28M | $561.67M | $557.71M | $163.12M | $197.70M | $183.93M | $263.71M | $265.39M | $274.46M |
| Shareholder equity | $1.09B | $1.09B | $815.89M | $447.15M | $464.44M | $514.21M | $114.60M | $71.00M | $23.29M | -$106.52M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $2.46B | $2.41B | $2.35B | $2.23B | $2.28B | $2.12B | $2.06B | $1.98B | $2.05B | $1.94B | $1.83B | $1.65B |
| Total liabilities | $1.10B | $1.10B | $1.13B | $1.14B | $1.16B | $949.29M | $891.03M | $892.33M | $869.92M | $913.15M | $885.79M | $835.26M |
| Cash and equivalents | $683.61M | $593.30M | $498.58M | $359.12M | $382.01M | $695.57M | $938.53M | $912.81M | $866.39M | $757.02M | $718.28M | $713.66M |
| Shareholder equity | $1.36B | $1.31B | $1.21B | $1.09B | $1.12B | $1.17B | $1.16B | $1.09B | $1.18B | $1.03B | $945.54M | $815.89M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 90.7% of operating cash flow.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $390.14M | $544.75M | $305.26M | $281.78M | $53.92M | $16.40M | $80.38M | $61.19M | $54.78M | $49.64M |
| Capital expenditures | $36.09M | $51.63M | $46.55M | $18.35M | $12.14M | $12.47M | $22.06M | $20.13M | $17.54M | $7.40M |
| Free cash flow | $354.05M | $493.13M | $258.70M | $263.43M | $41.78M | $3.92M | $58.32M | $41.06M | $37.23M | $42.24M |
| Dividends paid | N/A | N/A | N/A | N/A | $2.05M | $2.13M | $2.45M | N/A | $0 | $0 |
| Investing cash flow | -$627.17M | -$226.01M | $5.94M | -$276.55M | $3.68M | -$4.91M | -$22.06M | -$19.13M | -$16.31M | $3.28M |
| Financing cash flow | -$316.58M | -$118.54M | -$13.06M | $311.69M | -$39.33M | -$21.86M | -$78.88M | -$4.67M | -$13.45M | -$30.22M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $101.97M | $92.20M | $125.13M | $90.18M | $105.29M | $87.11M | $107.56M | $155.40M | $175.06M | $84.72M | $127.24M | $112.29M |
| Capital expenditures | $2.05M | $2.33M | $3.23M | $8.79M | $10.62M | $13.37M | $8.72M | $16.37M | $15.81M | $11.18M | $8.27M | $12.07M |
| Free cash flow | $99.93M | $89.87M | $121.90M | $81.39M | $94.67M | $73.73M | $98.84M | $139.03M | $159.25M | $73.55M | $118.97M | $100.22M |
Frequently Asked Questions About LNTH
What is Lantheus Holdings' annual revenue?
Lantheus Holdings reported revenue of $1.54B for the fiscal year ended Dec 31, 2025.
How fast is Lantheus Holdings' revenue growing?
Revenue was up 0.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 18.1%.
Is Lantheus Holdings profitable?
Yes. Lantheus Holdings reported net income of $233.56M for the fiscal year ended Dec 31, 2025, with a net margin of 15.2%.
How much free cash flow does LNTH generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $390.14M minus capital expenditures of $36.09M produced free cash flow of $354.05M.
How much debt does Lantheus Holdings have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $568.68M, short-term debt of $738.00K and cash and equivalents of $359.12M.
LNTH pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts